PCDH17_Pcdh17 Activators are a specialized group of chemical compounds that play a pivotal role in the regulation and enhancement of the function of PCDH17, a protein encoded by the Pcdh17 gene. This protein is part of the protocadherin family, which is involved in cell-cell adhesion and signal transduction, crucial for the development and maintenance of complex cellular structures and functions. The activators of PCDH17 are designed to potentiate its activity through various intracellular signaling cascades. For instance, compounds that can increase the intracellular calcium concentration indirectly promote the function of PCDH17, as calcium is a known cofactor for protocadherin function, facilitating the protein's ability to mediate cell adhesion. Activation of intracellular kinase pathways is another mechanism by which PCDH17 activators function; these pathways can lead to the phosphorylation of PCDH17 or associated proteins, thereby enhancing its adhesive capabilities.
These activators may also work by influencing the lipid composition of cellular membranes, which can alter the microenvironment in which PCDH17 operates, leading to enhanced protein function. Certain activators may interact with the cytoskeletal elements, modulating the dynamics of actin and influencing the clustering of PCDH17 at cellular junctions. This effect can potentiate the adhesive interactions that are mediated by PCDH17, reinforcing cell-cell communication and the integrity of cellular assemblies. The precise modulation of signaling pathways that intersect with those regulated by PCDH17 ensures that these activators can enhance the function of the protein without directly altering its expression levels. By fine-tuning the signaling environment, PCDH17 activators ensure that the protein's role in cellular adhesion and communication is optimized, supporting the maintenance of tissue architecture and the transmission of signals that govern cellular behavior and organization.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels by activating adenylyl cyclase, which then activates PKA. PKA phosphorylates targets, potentially including PCDH17_Pcdh17, thus enhancing its cell-cell adhesion function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which is involved in signal transduction and membrane trafficking. PKC phosphorylation events may increase PCDH17_Pcdh17's role in cellular adhesion. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates pathways that regulate cytoskeletal dynamics, potentially enhancing the adhesive roles of PCDH17_Pcdh17 in neurons. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits various protein kinases, potentially reducing negative regulation on pathways where PCDH17_Pcdh17 is active, thus enhancing its adhesion-related roles. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
By inhibiting PI3K, LY294002 may support PCDH17_Pcdh17's involvement in cellular adhesion and migration processes by affecting related intracellular signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, potentially activating pathways that could enhance PCDH17_Pcdh17's function in synaptic adhesion and neuronal signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium, potentially activating calmodulin-dependent kinases that could enhance PCDH17_Pcdh17-mediated cell-cell adhesion. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine may selectively inhibit kinases that negatively regulate adhesion pathways, possibly enhancing PCDH17_Pcdh17's adhesion activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein could enhance PCDH17_Pcdh17's adhesion functions by reducing competition from tyrosine kinase signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibiting p38 MAPK with SB203580 may shift the signaling balance to enhance pathways associated with PCDH17_Pcdh17's role in synaptic adhesion and plasticity. | ||||||